Preliminary scientific studies indicate conolidine may well inhibit unique ion channels, decreasing neuronal excitability and restricting pain indicators. This system is especially suitable in neuropathic agony, exactly where abnormal signaling results in persistent distress. In addition, conolidine seems to impact G protein-coupled receptor (GPCR)